Slaoui exits three more companies amid harassment falloutMoncef Slaoui has stepped down from positions at three more companies, shortly after being dismissed from a firm Share XSlaoui exits three more companies amid harassment fallouthttps://pharmaphorum.com/news/slaoui-exits-three-more-companies-amid-harassment-fallout/
Shock as AstraZeneca’s charismatic cancer R&D chief José Baselga diesAstraZeneca is mourning the loss of one of its top scientists after eminent cancer researcher José Baselga passed Share XShock as AstraZeneca’s charismatic cancer R&D chief José Baselga dieshttps://pharmaphorum.com/news/shock-as-astrazenecas-charismatic-cancer-rd-chief-jose-baselga-dies/
Almirall names Nazzi as new CEO after Guenter leaves for MerckSpanish drugmaker Almirall has lined up its new CEO following the departure of Peter Guenter, who left to Share XAlmirall names Nazzi as new CEO after Guenter leaves for Merckhttps://pharmaphorum.com/news/almirall-names-nazzi-as-new-ceo-after-guenter-leaves-for-merck/
Guido Rasi steps down, handing the running of EMA to Emer CookeEMA executive director Guido Rasi has ended his second term at the helm of the EU medicines regulator, Share XGuido Rasi steps down, handing the running of EMA to Emer Cookehttps://pharmaphorum.com/news/guido-rasi-steps-down-handing-the-running-of-ema-to-emer-cooke/
Lilly’s chief digital officer Aarti Shah announces retirementEli Lilly’s chief information and digital officer (CIDO) Aarti Shah is leaving the company next year after 27 Share XLilly’s chief digital officer Aarti Shah announces retirementhttps://pharmaphorum.com/news/lillys-chief-digital-officer-aarti-shah-announces-retirement/
Roger Perlmutter leaves Merck after 7 years, joins board at InsitroRoger Perlmutter has brought a seven-year stint as head of R&D at Merck & Co/MSD to a close, Share XRoger Perlmutter leaves Merck after 7 years, joins board at Insitrohttps://pharmaphorum.com/news/roger-perlmutter-leaves-merck-after-7-years-joins-board-at-insitro/
Indivior ex-CEO could face jail time after opioid convictionThe resignation of Indivior chief executive Shaun Thaxter this week was swiftly followed by a guilty plea – Share XIndivior ex-CEO could face jail time after opioid convictionhttps://pharmaphorum.com/news/indivior-ex-ceo-could-face-jail-time-after-opioid-conviction/
David Loew swaps Sanofi’s top vaccine job for CEO role at IpsenSanofi had no sooner announced the departure of David Loew, its head of vaccines, before he surfaced as Share XDavid Loew swaps Sanofi’s top vaccine job for CEO role at Ipsenhttps://pharmaphorum.com/news/david-loew-swaps-sanofis-top-vaccine-job-for-ceo-role-at-ipsen/
NICE names Gillian Leng as CEO, replacing Andrew DillonNICE has appointed Prof Gillian Leng as its new chief executive, completing its top leadership search after new Share XNICE names Gillian Leng as CEO, replacing Andrew Dillonhttps://pharmaphorum.com/news/nice-names-gillian-leng-as-ceo-replacing-andrew-dillon/
